Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Incyte Corp (INCY)  
$52.05 0.51 (0.97%) as of 4:30 Tue 4/30


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 219,000,000
Market Cap: 11.40(B)
Last Volume: 4,773,244 Avg Vol: 1,580,128
52 Week Range: $51.18 - $75.34
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  144
Guru Rank Value     : 7.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. JAKAFI (ruxolitinib) is Co.'s initial product approved by the U.S. Food and Drug Administration for the treatment of adults with intermediate or high-risk myelofibrosis, for the treatment of adults with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea, for the treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients 12 years and older and for the treatment of chronic GVHD after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 9,299 39,259 138,275
Total Sell Value $0 $603,781 $2,515,280 $10,787,547
Total People Sold 0 3 4 7
Total Sell Transactions 0 4 6 15
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 270
  Page 6 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Pasquale Maria E EVP & General Counsel   •       –      –    2021-03-12 4 OE $65.36 $8,366 D/D 128 30,328     -
   Dhanak Dashyant EVP & Chief Scientific Officer   •       –      –    2021-03-01 4 AS $79.73 $31,493 D/D (395) 27,732 3%     
   Hoppenot Herve Chairman / CEOPresident   •       •      –    2021-02-23 4 B $77.37 $1,000,007 D/D 12,925 284,231 2.81 6%     
   Pasquale Maria E EVP & General Counsel   •       –      –    2021-02-16 4 OE $65.36 $8,301 D/D 127 30,200     -
   Stamoulis Christiana EVP & Chief Financial Officer   •       –      –    2021-02-11 4 D $84.99 $102,838 D/D (1,210) 32,611     -
   Dhanak Dashyant EVP & Chief Scientific Officer   •       –      –    2021-02-01 4 AS $90.00 $122,040 D/D (1,356) 28,127 -9%     
   Dhanak Dashyant EVP & Chief Scientific Officer   •       –      –    2021-02-01 4 OE $65.42 $62,869 D/D 961 29,483     -
   Iyengar Vijay K EVP GPS, BD, & Licensing   •       –      –    2021-01-25 4 AS $99.00 $506,484 D/D (5,116) 26,158 -17%     
   Iyengar Vijay K EVP GPS, BD, & Licensing   •       –      –    2021-01-25 4 OE $72.86 $299,892 D/D 4,116 31,274     -
   Stein Steven H EVP & Chief Medical Officer   •       –      –    2021-01-25 4 AS $100.00 $379,500 D/D (3,795) 119,744 -17%     
   Stein Steven H EVP & Chief Medical Officer   •       –      –    2021-01-25 4 OE $68.62 $260,413 D/D 3,795 123,539     -
   Wenqing Yao EVP, Head of Discovery Chem   •       –      –    2021-01-25 4 AS $100.00 $2,154,500 D/D (21,545) 143,784 -17%     
   Wenqing Yao EVP, Head of Discovery Chem   •       –      –    2021-01-25 4 OE $73.21 $1,577,309 D/D 21,545 163,770     -
   Morrissey Michael James EVP, Head of Tech. Operations   •       –      –    2021-01-25 4 D $100.50 $7,839 D/D (78) 65,452     -
   Flannelly Barry P EVP & General Manager US   •       –      –    2021-01-25 4 AS $100.00 $274,400 D/D (2,744) 49,994 -17%     
   Dickinson Jonathan Elliott EVP, General Manager, Europe   •       –      –    2021-01-25 4 D $100.50 $7,839 D/D (78) 27,135     -
   Dickinson Jonathan Elliott EVP, General Manager, Europe   •       –      –    2021-01-19 4 D $93.96 $16,349 D/D (174) 27,213     -
   Morrissey Michael James EVP, Head of Tech. Operations   •       –      –    2021-01-19 4 D $93.96 $16,349 D/D (174) 65,530     -
   Wenqing Yao EVP, Head of Discovery Chem   •       –      –    2021-01-15 4 A $0.00 $0 D/D 11,522 143,784     -
   Trower Paul Principal Accounting Officer   •       –      –    2021-01-15 4 A $0.00 $0 D/D 4,032 28,427     -
   Stamoulis Christiana EVP & Chief Financial Officer   •       –      –    2021-01-15 4 A $0.00 $0 D/D 11,522 33,821     -
   Stein Steven H EVP & Chief Medical Officer   •       –      –    2021-01-15 4 A $0.00 $0 D/D 23,044 119,744     -
   Dickinson Jonathan Elliott EVP, General Manager, Europe   •       –      –    2021-01-15 4 A $0.00 $0 D/D 5,761 27,387     -
   Flannelly Barry P EVP & General Manager US   •       –      –    2021-01-15 4 A $0.00 $0 D/D 11,522 52,738     -
   Morrissey Michael James EVP, Head of Tech. Operations   •       –      –    2021-01-15 4 A $0.00 $0 D/D 17,283 65,704     -
  270 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us